Clinical course of hypertrophic cardiomyopathy in an unselected population. The Italian multicenter cardiomyopathy study (SPIC) experience;Decorso clinico della cardiomiopatia ipertrofica in una popolazione non selezionata. L'esperienza dello Studio Policentrico Italiano Cardiomiopatie (SPIC)

Giornale Italiano di Cardiologia

Volumn 27, Issue 11, 1997, Pages 1133-1143

  Cecchi, Franco ^a,f   Olivotto, Iacopo ^a   Lazzeroni, Ettore ^b   Chiriatti, Giampaolo ^c   Sachero, Aldo ^d   Beretta, Luciano ^d   Giagnoni, Erminia ^d   Renosto, Giuliano ^e   Montereggi, Alessio ^a   Baldassarre, Silvia ^a   Castelli, Gabriele ^a   Ciaccheri, Mauro ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b Azienda Ospedaliera   (Italy)

^c Ospedale   (Italy)

^d Azienda USSL 37   (Italy)

^e Presidio Ospedaliero Multizonale   (Italy)

^f NONE   (Italy)

Author keywords

Atrial fibrillation; Heart failure; Hypertrophic cardiomyopathy; Sudden cardiac death; Syncope

Indexed keywords

ADULT; ARTICLE; CARDIOMYOPATHY; DISEASE COURSE; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MORTALITY; SUDDEN DEATH;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CARDIOMYOPATHY, HYPERTROPHIC; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; DEATH, SUDDEN, CARDIAC; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; INFANT; ITALY; MALE; MIDDLE AGED; SURVIVAL RATE; SYNCOPE; TACHYCARDIA, VENTRICULAR;

EID: 9844237582     PISSN: 00465968     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. MARON BJ, BONOW RO, CANNON RO, LEON MB, EPSTEIN SE: Hypertrophic cardiomyopathy: interrelation of clinical manifestations, pathophysiology, and therapy. N Engl J Med 1987; 316: 780-789, 844-852.
2. WIGLE ED, SASSON Z, HENDERSON MA, ET AL: Hypertrophic cardiomyopathy: the importance of the site and extent of hypertrophy - a review. Progr Cardiovasc Dis 1985; 28: 1-83.
3. WATKINS H, ROSENZWEIG A, HWANG D-S, ET AL: Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992; 326: 1108-1114.
4. MARON BJ, GOTTDIENER JS, EPSTEIN SE: Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a wide angle, two-dimensional echocardiographic study of 125 patients. Am J Cardiol 1981; 48: 418-428.
5. CIRÒ E, NICHOLS PF, MARON BJ: Heterogeneous morphologic expression of genetically transmitted hypertrophic cardiomyopathy: two-dimensional echocardiographic analysis. Circulation 1983; 67: 1227-1233.
6. SOLOMON SD, JARCHO JA, MCKENNA WJ, ET AL: Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease. J Clin Invest 1990; 86: 993-999.
7. SPIRITO P, MARON BJ, BONOW RO, EPSTEIN SE: Severe functional limitation in patients with hypertrophic cardiomyopathy and only mild localized left ventricular hypertrophy. J Am Coll Cardiol 1986; 8: 537-544.
8. YAMAGUCHI H, ISHIMURA T, NISHIYAMA S, ET AL: Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol 1979; 44: 401-412.
9. LOUIE EK, MARON BJ: Apical hypertrophic cardiomyopathy: clinical and two-dimensional echocardiographic assessment. Ann Intern Med 1987; 106: 663-670.
10. ALFONSO F, NIHOYANNOPOULOS P, STEWART J, DICKI S, LEMERY R, MCKENNA WJ: Clinical significance of giant negative T waves in hypertrophic cardiomyopathy. J Am Coll Cardiol 1990; 15: 965-971.
11. KLUES HG, MARON BJ, DOLLAR AL, ROBERTS WC: Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation 1992; 85: 1651-1660.
12. HECHT GM, KLUES HG, ROBERTS WC, MARON BJ: Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy. J Am Coll Cardiol 1993; 22: 489497.
13. FIGHALI S, KRAJCER Z, EDELMAN S, LEACHMAN RD: Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: higher incidence in patients with midventricular obstruction. J Am Coll Cardiol 1987; 9: 288-294.
14. SPIRITO P, SEIDMAN CE, MCKENNA WJ, MARON BJ: The management of hypertrophic cardiomyopathy. N Engl J Med 1997; 336: 775-785.
15. SHAPIRO LM, MCKENNA WJ: Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. J Am Coll Cardiol 1983; 2: 437-444.
16. MARON BJ, EPSTEIN SE: Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol 1979; 43: 1242-1244.
17. ADELMAN AG, WIGLE ED, RANGANATHAN N, WEBB GD, KIDD BSL, BIGELOW WG: The clinical course in muscular subaortic stenosis: a retrospective and prospective study of 60 hemodynamically proved cases. Ann Intern Med 1972; 77: 515-525.
18. MCKENNA W, DEANFIELD J, FARUQUI A, ENGLAND D, OAKLEY C, GOODWIN J: Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 1981; 47: 532-538.
19. FRANK S, BRAUNWALD E: Idiopathic hypertrophic subaortic stenosis: clinical analysis of 126 patients with emphasis on the natural history. Circulation 1968; 37: 759-788.
20. SHAH PM, ADELMAN AG, WIGLE ED, ET AL: The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy. Circ Res 1973; 34, 35 (Suppl 2): 179-195.
21. Maron BJ, Roberts WC, Epstein SE: Sudden death in hypertrophic cardiomyopathy: profile of 78 patients. Circulation 1982; 65: 1388-1394.
22. SWAN DA, BELL B, OAKLEY C, GOODWIN J: Analysis of symptomatic course and prognosis and treatment of hypertrophic obstructive cardiomyopathy. Br Heart J 1971; 33: 671-685.
23. HARDARSON T, DE LA CALZADA CS, CURIEL R, GOODWIN JF: Prognosis and mortality of hypertrophic obstructive cardiomyopathy. Lancet 1973; 2: 1462-1467.
24. LOOGEN F, KUHN H, GIETZEN F, LOSSE B, SCHULTE HD, BIRCKS W: Clinical course and prognosis of patients with typical and atypical hypertrophic obstructive and with hypertrophic non-obstructive cardiomyopathy. Eur Heart J 1983; 4 (Suppl F): 145-153.
25. HECHT GM, PANZA JA, MARON BJ: Clinical course of middle-aged asymptomatic patients with hypertrophic cardiomyopathy. Am J Cardiol 1992; 69: 935-940.
26. MCKENNA WJ, DEANFIELD JE: Hypertrophic cardiomyopathy: an important cause of sudden death. Arch Dis Child 1984; 59: 971-975.
27. MARON BJ, LIPSON LC, ROBERTS WC, SAVAGE DD, EPSTEIN SE: "Malignant" hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature deaths. Am J Cardiol 1978; 1133-1140.
28. FIDDLER GI, TAJIK AJ, WEIDMAN WH, MCGOOD DC, RITTER DG, GIULIANI ER: Idiopathic hypertrophic subaortic stenosis in the young. Am J Cardiol 1978; 42: 793-799.
29. CECCHI F, MARON BJ, EPSTEIN SE: Long-term outcome of patients with hypertrophic cardiomyopathy successfully resuscitated after cardiac arrest. J Am Coll Cardiol 1989; 13: 1283-1288.
30. MCKENNA WJ, CAMM AJ: Sudden death in hypertrophic cardiomyopathy: assessment of patients at high risk. Circulation 1989; 80: 1489-1492.
31. MARON BJ, HENRY WL, CLARK CE, REDWOOD DR, ROBERTS WC, EPSTEIN SE: Asymmetric septal hypertrophy in childhood. Circulation 1976; 53: 9-18.
32. SPIRITO P, CHIARELLA F, CARRATINO L, BERISSO MZ, BELLOTTI P, VECCHIO C: Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med 1989; 320: 749-755.
33. SHAPIRO LM, ZEZULKA A: Hypertrophic cardiomyopathy: a common disease with a good prognosis. Five-year experience of a district general hospital. Br Heart J 1983; 50: 530-533.
34. KOFFLARD MJ, WALDSTEIN DJ, VOS J, TEN CATE FJ: Prognosis in hypertrophic cardiomyopathy: long-term follow-up in a large, unselected outpatient population. Am J Cardiol 1993; 72: 939-943.
35. CANNAN CR, REEDER GS, BAILEY KR, MELTON LJ III, GERSH BJ: Natural history of hypertrophic cardiomyopathy: a population-based study, 1976 through 1990. Circulation 1995; 92: 2488-2495.
36. CECCHI F, OLIVOTTO I, MONTEREGGI A, SANTORO G, DOLARA A, MARON BJ: Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected population. J Am Coll Cardiol 1995; 26: 1529-1536.
37. SPIRITO P, SEIDMAN CE, MCKENNA WJ, MARON BJ: The management of hypertrophic cardiomyopathy. N Engl J Med 1997; 336: 775-785.
38. MARON BJ, CECCHI F, MCKENNA WJ: Risk factors and current status of risk stratification profiles for sudden cardiac death in patients with hypertrophic cardiomyopathy. Br Heart J 1994; 72 (Suppl): 13-18.
39. PANZA JA, PETRONE RK, FANANAPAZIR L, MARON BJ: Utility of continuous-wave Doppler in noninvasive assessment of the left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1992; 19: 91-99.
40. DIAMOND GA, FORRESTER JS: Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med 1979; 300: 1350-1358.
41. MCKENNA WJ, OAKLEY CM, KRIKLER DM, GOODWIN JF: Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia. Br Heart J 1985; 53: 412-416.
42. KAPLAN E, MEIER P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
43. Cox DR: Regression models and life tables (with discussion). J R Statist Soc B 1972; 34: 187-220.
44. SPIRITO P, LAKATOS E, MARON BJ: Degree of left ventricular hypertrophy in patients with hypertrophic cardiomyopathy and chronic atrial fibrillation. Am J Cardiol 1992; 69: 1217-1222.
45. SPIRITO P, MARON BJ, BONOW RO, EPSTEIN SE: Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in patients with hypertrophic cardiomyopathy. Am J Cardiol 1987; 60: 123-129.
46. MARON BJ, EPSTEIN SE, ROBERTS WC: Hypertrophic cardiomyopathy and transmural myocardial infarction without significant atherosclerosis of the extramural coronary arteries. Am J Cardiol 1979; 43: 1086-1102.
47. MARON BJ, GARDIN JM, FLACK JM, GIDDING SS, KUROSAKI TT, BILD DE: Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation 1995; 92: 530-533.
48. MARON BJ, SPIRITO P: Impact of patient selection biases on the perception of hypertrophic cardiomyopathy and its natural history. Am J Cardiol 1993; 72: 970-972.
49. MARON BJ, EPSTEIN SE: Clinical significance and therapeutic implications of the left ventricular outflow tract pressure gradient in hypertrophic cardiomyopathy. Am J Cardiol 1986; 58: 1093-1096.
50. MARON BJ, SAVAGE DD, WOLFSON JK, EPSTEIN SE: Prognostic significance of 24-hour ambulatory electrocardio-graphic monitoring in patients with hypertrophic cardiomyopathy: a prospective study. Am J Cardiol 1981; 48: 252-257.
51. SAVAGE DD, SEIDES SF, MARON BJ, MYERS DJ, EPSTEIN SE: Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation 1979; 59: 866-875.
52. NIENABER CA, HILLER S, SPIELMAN RP, GEIGER M, KUCH K-H: Syncope in hypertrophic cardiomyopathy: multivariate analysis of prognostic determinants. J Am Coll Cardiol 1990; 15: 948-955.
53. FANANAPAZIR L, CHANG AC, EPSTEIN SE, MCAREAVEY D: Prognostic determinants in hypertrophic cardiomyopathy: prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic and electrophysiological findings. Circulation 1992; 86: 730-740.
54. WIGLE ED, RAKOWSKI H, KIMBALL BR, WILLIAMS WG: Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 1995; 92: 1680-1692.
55. GLANCY DL, O'BRIEN KP, GOLD HK, EPSTEIN SE: Atrial fibrillation in patients with idiopathic hypertrophic subaortic stenosis. Br Heart J 1970; 32: 652-659
56. ROBINSON KC, FRENNEAUX MP, STOCKINS B, KARATASAKIS G, POLONIECKI JD, MCKENNA WJ: Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. J Am Coll Cardiol 1990; 15: 1279-1285.